FinTechFunding

Genetic Technologies: Acquires EasyDNA for $5.4M

Genetic Technologies Acquires EasyDNA for $5.4M

  • Genetic Technologies (GTG) acquires EasyDNA for around $5.4 million in cash and scrip
  • Under the contract, GTG obtains all of Belhealth’s websites, lab testing and distribution agreements associated with its EasyDNA business
  • EasyDNA sells paternity, oncology and health genomics-based laboratory tests, with agreements across 12 labs in North America, Europe and Asia
  • GTG says it will onboard the existing EasyDNA team, retaining the skills of all employees based in Malta and Australia
  • The company says the acquisition will provide it with the foundation to grow its portfolio of serious disease tests across well-established websites in 40 countries
  • The company closed flat at 0.8 cents per share
Previous article
Dimerix: Receives FDA feedback for DMX-200 trial
Next article
ProciseDx: Raises $13M in Convertible Note Financing
Steve Sam
Steve Sam
Steve Sam is a financial reporter, analyst, and commentator with a strong focus on banking technology, digital payments, and the future of financial services.

You May Also Like

FinTech

Visa Launches Validator Node on Tempo Blockchain, Strengthening Payments Infrastructure

New validator node aims to boost transaction efficiency for Visa services.Highlights: Visa launches a new validator node on...
FinTech

Amex Launches Agentic Commerce Development Kit to Strengthen Merchant Services

New toolkit aims to enhance payment solutions for businesses.Highlights: Amex unveils Agentic Commerce Development Kit for merchants.The toolkit...
FinTech

Hokodo B2B Buy Now Pay Later App Shuts Down

The closure impacts small businesses utilizing Hokodo’s service.Highlights: Hokodo, the B2B Buy Now Pay Later app, has ceased...
FinTech

Deutsche Börse Invests in Kraken, Strengthening Crypto Market Position

The investment aims to enhance Kraken's offerings and expand market access.Highlights: Deutsche Börse invests in Kraken to boost...